Asthma and COPD Drugs Market: How Are Biologic Therapies Reshaping the Treatment Landscape for Severe Asthma?
Biologic therapy's transformation of severe asthma management — the anti-IgE, anti-IL-5, anti-IL-4/13, and anti-TSLP monoclonal antibodies targeting the upstream type 2 inflammatory pathways driving eosinophilic and allergic asthma phenotypes creating unprecedented disease control in patients previously reliant on chronic oral corticosteroids — represents the most significant...
0 Commentaires 0 Parts 36 Vue 0 Aperçu